134 related articles for article (PubMed ID: 6390794)
21. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine, carbamazepine-10,11-epoxide and phenytoin concentrations in brain tissue of epileptic children.
Friis ML; Christiansen J
Acta Neurol Scand; 1978 Aug; 58(2):104-8. PubMed ID: 707037
[TBL] [Abstract][Full Text] [Related]
23. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
MacKichan JJ; Duffner PK; Cohen ME
Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
[TBL] [Abstract][Full Text] [Related]
24. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
25. Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Gobbi G; Cortelli P; Procaccianti G; Baruzzi A
Ther Drug Monit; 1984; 6(4):408-13. PubMed ID: 6542700
[TBL] [Abstract][Full Text] [Related]
26. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
27. The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, comedication, and relation to outcome of pregnancy.
Omtzigt JG; Los FJ; Meijer JW; Lindhout D
Ther Drug Monit; 1993 Feb; 15(1):1-10. PubMed ID: 8451773
[TBL] [Abstract][Full Text] [Related]
28. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Friis ML; Christiansen J; Hvidberg EF
Eur J Clin Pharmacol; 1978 Nov; 14(1):47-51. PubMed ID: 729606
[TBL] [Abstract][Full Text] [Related]
29. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
Vasudev A; Tripathi KD; Puri V
Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
[TBL] [Abstract][Full Text] [Related]
30. Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography.
Paxton JW
Epilepsia; 1982 Apr; 23(2):185-9. PubMed ID: 7042328
[TBL] [Abstract][Full Text] [Related]
31. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
van Belle G; Friel PN
Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931
[TBL] [Abstract][Full Text] [Related]
32. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].
Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR
Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769
[TBL] [Abstract][Full Text] [Related]
33. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation.
Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M
Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
36. Influence of additional therapy with zonisamide (Excegran) on protein binding and metabolism of carbamazepine.
Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S; Aoyama T
Epilepsia; 1994; 35(5):1023-5. PubMed ID: 7925145
[TBL] [Abstract][Full Text] [Related]
37. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
38. Progabide-induced changes in carbamazepine metabolism.
Graves NM; Fuerst RH; Cloyd JC; Brundage RC; Welty TE; Leppik IE
Epilepsia; 1988; 29(6):775-80. PubMed ID: 3191894
[TBL] [Abstract][Full Text] [Related]
39. Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Liu H; Delgado MR
Epilepsia; 1995 Mar; 36(3):249-54. PubMed ID: 7614908
[TBL] [Abstract][Full Text] [Related]
40. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
